Related Experiment Video

Updated: Sep 2, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival

Immunotargets and Therapy

|September 1, 2026

Abstract:

[This retracts the article DOI: 10.2147/ITT.S603087.].

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

VISTA Confers Renal Protection in Murine Hemorrhage/Infection-Induced Acute Kidney Injury: Associations with Altered NGAL and HMGB1 Expression.

ImmunoTargets and therapy·2026

Exploring the Potential Benefits of Biologic Therapies Beyond Respiratory Allergy.

ImmunoTargets and therapy·2026

The Multifaceted Roles of STAT6: Implications for Precision Immunotherapeutics.

ImmunoTargets and therapy·2026

A Single-Cell-Derived CD8+ T-Cell State Plasticity Score for Prognostic Stratification and Characterization of Immune Responsiveness in Hepatocellular Carcinoma.

ImmunoTargets and therapy·2026

Associations of Nonspecific Autoantibodies with Recurrent Pregnancy Loss and Pregnancy Outcomes Following Immunological Intervention: A Single-Centre Retrospective Cohort Study.

ImmunoTargets and therapy·2026

ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells.

ImmunoTargets and therapy·2026

See all related articles